GBS Inc. Reports Fourth Quarter and Full Year ended June
- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective...
Source: globenewswire.com
Glucose Biosensor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Glucose Biosensor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Glucose Biosensor Today - Breaking & Trending Today
GBS, Inc. (GBS) Q4 2022 Earnings Call Transcript
GBS, Inc. (NASDAQ:NASDAQ:GBS) Q4 2022 Earnings Conference Call August 31, 2022, 04:30 PM ET Company Participants Steven Boyages - Chairman and Interim CEO Spiro Sakiris - CFO Conference...
Source: seekingalpha.com
GBS Inc. Reports Fourth Quarter and Full Year ended June 30, 2022 Preliminary Financial Results and Recent Business Highlights
31.08.2022 - - Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral ...
Source: wallstreet-online.de
IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant - ABN Newswire (@ABN_Newswire)
IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant Portfolio Company Awarded $6.3M Federal Govt GrantSydney, July 9, 2021 AEST (ABN Newswire) - iQX Limited ( NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, that LSBD's subsidiary GBS today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant to create a pilot Biosensor manufacturing facility. GBS Inc ( NASDAQ:GBS) is a life sciences company developing non-invasive, real-time diagnostic testing for patients...
Source: abnnewswire.net